Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 541 to 543 of 543 entries
Sorted by: Best Match Show Resources per page
Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP.

Diabetologia

Hiller H, Yang C, Beachy DE, Kusmartseva I, Candelario-Jalil E, Posgai AL, Nick HS, Schatz D, Atkinson MA, Wasserfall CH.
PMID: 34274990
Diabetologia. 2021 Oct;64(10):2279-2291. doi: 10.1007/s00125-021-05501-8. Epub 2021 Jul 17.

AIMS/HYPOTHESIS: Normal cellular prion protein (PrPMETHODS: In order to evaluate localisation and trafficking of PrPRESULTS: In non-diabetic and type 1 diabetic pancreases (the latter displaying both insulin-positive [INS(+)] and -negative [INS(-)] islets), we found PrPCONCLUSIONS/INTERPRETATION: As the first study...

Cite
Hiller H, Yang C, Beachy DE, et al. Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP. Diabetologia. 2021;64(10):2279-2291doi: 10.1007/s00125-021-05501-8.
Hiller, H., Yang, C., Beachy, D. E., Kusmartseva, I., Candelario-Jalil, E., Posgai, A. L., Nick, H. S., Schatz, D., Atkinson, M. A., & Wasserfall, C. H. (2021). Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP. Diabetologia, 64(10), 2279-2291. https://doi.org/10.1007/s00125-021-05501-8
Hiller, Helmut, et al. "Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP." Diabetologia vol. 64,10 (2021): 2279-2291. doi: https://doi.org/10.1007/s00125-021-05501-8
Hiller H, Yang C, Beachy DE, Kusmartseva I, Candelario-Jalil E, Posgai AL, Nick HS, Schatz D, Atkinson MA, Wasserfall CH. Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP. Diabetologia. 2021 Oct;64(10):2279-2291. doi: 10.1007/s00125-021-05501-8. Epub 2021 Jul 17. PMID: 34274990.
Copy Download .nbib Format: NLM
A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.

Cancers

Krassnig S, Wohlrab C, Golob-Schwarzl N, Raicht A, Schatz C, Birkl-Toeglhofer AM, Skofler C, Gantenbein N, Leoni M, Asslaber M, Leber SL, Mahdy-Ali K, von Campe G, Mayer M, Borenich A, Weis S, Benesch M, Haybaeck J.
PMID: 33807050
Cancers (Basel). 2021 Mar 23;13(6). doi: 10.3390/cancers13061482.

Glioblastoma (GBM) is an utterly devastating cerebral neoplasm and current therapies only marginally improve patients' overall survival (OS). The PI3K/AKT/mTOR pathway participates in gliomagenesis through regulation of cell growth and proliferation. Since it is an upstream regulator of the...

Cite
Krassnig S, Wohlrab C, Golob-Schwarzl N, et al. A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy. Cancers (Basel). 2021;13(6)doi: 10.3390/cancers13061482.
Krassnig, S., Wohlrab, C., Golob-Schwarzl, N., Raicht, A., Schatz, C., Birkl-Toeglhofer, A. M., Skofler, C., Gantenbein, N., Leoni, M., Asslaber, M., Leber, S. L., Mahdy-Ali, K., von Campe, G., Mayer, M., Borenich, A., Weis, S., Benesch, M., & Haybaeck, J. (2021). A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy. Cancers, 13(6), . https://doi.org/10.3390/cancers13061482
Krassnig, Stefanie, et al. "A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy." Cancers vol. 13,6 (2021). doi: https://doi.org/10.3390/cancers13061482
Krassnig S, Wohlrab C, Golob-Schwarzl N, Raicht A, Schatz C, Birkl-Toeglhofer AM, Skofler C, Gantenbein N, Leoni M, Asslaber M, Leber SL, Mahdy-Ali K, von Campe G, Mayer M, Borenich A, Weis S, Benesch M, Haybaeck J. A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy. Cancers (Basel). 2021 Mar 23;13(6). doi: 10.3390/cancers13061482. PMID: 33807050; PMCID: PMC8004965.
Copy Download .nbib Format: NLM
How Physician Workforce Shortages Are Hampering the Response to the Opioid Crisis.

Psychiatric services (Washington, D.C.)

McNeely J, Schatz D, Olfson M, Appleton N, Williams AR.
PMID: 34521210
Psychiatr Serv. 2021 Sep 15;appips202000565. doi: 10.1176/appi.ps.202000565. Epub 2021 Sep 15.

The United States is experiencing an unprecedented opioid crisis, with a record of about 93,000 opioid-involved overdose deaths in 2020, which requires rapid and substantial scaling up of access to effective treatment for opioid use disorder. Only 18% of...

Cite
McNeely J, Schatz D, Olfson M, et al. How Physician Workforce Shortages Are Hampering the Response to the Opioid Crisis. Psychiatr Serv. 2021;appips202000565doi: 10.1176/appi.ps.202000565.
McNeely, J., Schatz, D., Olfson, M., Appleton, N., & Williams, A. R. (2021). How Physician Workforce Shortages Are Hampering the Response to the Opioid Crisis. Psychiatric services (Washington, D.C.), appips202000565. https://doi.org/10.1176/appi.ps.202000565
McNeely, Jennifer, et al. "How Physician Workforce Shortages Are Hampering the Response to the Opioid Crisis." Psychiatric services (Washington, D.C.) vol. (2021): appips202000565. doi: https://doi.org/10.1176/appi.ps.202000565
McNeely J, Schatz D, Olfson M, Appleton N, Williams AR. How Physician Workforce Shortages Are Hampering the Response to the Opioid Crisis. Psychiatr Serv. 2021 Sep 15;appips202000565. doi: 10.1176/appi.ps.202000565. Epub 2021 Sep 15. PMID: 34521210.
Copy Download .nbib Format: NLM
Showing 541 to 543 of 543 entries